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animals (p<0.05). Estrogen treatment effectively prevented the 
early rise in CTX II levels as well as the development of carti- 
lage erosion at Week 9 (p<0.05). In contrast, estrogen replace- 
ment initiated 3 weeks after ovariectomy exerted similar effects 
on CTX II levels, but achived only a partial prevention of cartilage 
erosions. Under ex vivo conditions, exposure of articular carti- 
lage explants to OSM and TNF-o~ induced a 200-fold increase 
in CTX-II release (at Day 13) compared to unstimulated control 
explants. The increase in collagen type II degradation could be 
effectively and dose-dependently countered by co-administration 
of 171~-estradiol. 
Conclusion: Estrogen therapy initiated in the early phase of the 
menopause provides an effective prevention of the acceleration of 
cartilage degradation and related cartilage damage in OVX rats. 
Results of the ex vivo experiments uggest that part of the chon- 
droprotective ffects exerted by estrogen represent direct effects 
on chrondrocytes. These results warrant further investigation of 
the chondroprotective effect of estrogen and estrogen-like sub- 
stances such as SERMs. 
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Background: Death of chondrocyte cells by apoptosis is a hall- 
mark of degenerative joint diseases such as osteoarthritis (OA). 
Combination of Tumour Necrosis Factor o~ (TNF-o 0 and Actino- 
mycin D (ActD) or TNF-o~ and Ro 31-8220 have been proved to in- 
duce apoptosis in chondrocytes. Both ActD and Ro 31-8220 are, 
although much more specific the second one, inhibitors of Mito- 
gen Kinase Phosphatase 1 (MKP-1) expresion. Tumour Growth 
Factor I~-1 (TGF-I~I) is a multifunctional citoquine that provides 
signals for both cell survival and apoptosis, the final output de- 
pending on cell type and cellular context. 
Objectives: In this work, we studied if TGF-I~I is able to protect 
human chondrocytes from apoptosis induced by two in vitro mod- 
els which use inhibition of MKP-1 as one of their major target: 
TNF-o~ +ActD and TNF-o~ + Ro31-8220. Furthermore, we asses 
the effect of TGF- I~1 on mitochondrial activity. 
Methods: Human OA cartilage was obtained from the femoral 
heads of 8 patients who were undergoing joint replacement 
surgery. Cell viability was asessed by MTT assay, apoptosis by 
flow cytometry (propidium iodide) and ELISA cell death and nu- 
clear morphological cell analysis by DAPI. To determine intra- 
cellular ATP levels, a luminescence ATP detection assay system 
based on the production of light caused by the reaction of ATP 
with added luciferase and D-luciferin was employed. 
Results: It was established two groups of cells; only one of 
them was preincubated for 120h with TGF-I~I. Afterwards, both 
groups were stimulated with TNF- o~ and ActD or TNF- o~ and 
Ro 31-8220 for 16h. The viability (Basal 100%) decrease sig- 
nificantly in the non TGF-I~I preincubated group (TNF-o~+ActD 
71.0% vs TGF-I~I + TNF-o~+ActD 86.7%, p< 0.05; TNF-o~+Ro 31- 
8220 67.0% vs TGF-I~I + TNF-o~+ActD 86.9%, p<0.05). Moreover, 
TGF-I~I significantly reduced the percentage of hypodiploid chon- 
drocytes (TN F-o~+ActD 15.9% vs TGF-I~I + TNF-o~+ActD 9.5%, p< 
0.01; TNF-o~+Ro 31-8220 13.0% vs TGF-I~I + TNF-o~+Ro 31-8220 
5.7%, p< 0.05), just as the percentage of internucleosomal DNA 
breakage (TNF-o~+ActD 100% vs TGF-I~I+ TNF-o~+ActD 70.5%, 
p< 0.05), induced by MKP-1 inhibition. Furthermore, morpholog- 
ical analysis by DAPI fits well with previous results. Finally, to ex- 
amine the role of mitochondria in the protection by TGF-I~I, we 
studied the effect on ATP synthesis, proving an exponential in- 
crease along the time (96h data; TGF-I~I 289.8% vs Basal 100%, 
p<0.01). 
Conclusion: These results show that TGF-I~I is able to partially 
blocks the apoptosis induced by TNF-o~+ActD and TNF-o~+Ro 31 - 
8220, which give insights into a probable protector ole through 
the modulation of the MKP-1 activity. Furthermore, mitochondrial 
activity also seems to have a major role in this protection. 
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Aim: Degeneration and the loss of extracellular matrix macro- 
molecules from cartilage result in serious impairment of joint 
function. To determine how the extracellular matrix protein 
matrilin-2 is degraded in cartilage, we identified the extracellu- 
lar proteinase that cleaves matrilin-2, and the pro-inflammatory 
conditions under which matrilin-2 is cleaved. 
Method: Recombinant matrilin-2 protein was generated from ex- 
pression in mammalian cells of a matrilin-2 cDNA cloned from 
mouse cartilage. Three matrilin-2 deletion cDNA constructs were 
generated by overlapping PCR. These constructs were trans- 
fected into COS-1 cells, and conditioned medium was collected. 
Human articular chondrocytes were incubated with the condi- 
tioned medium containing matrilin-2 in the presence of 10ng/ml 
IL-la or 10ng/ml TGF-b. Furthermore, matrilin-2 recombinant 
protein was purified from conditioned medium and incubated with 
recombinant ADAMTS4. Matrilin-2 cleavage products were iden- 
tified by western blot analysis and SELDI mass spectrometry. 
Result: We affinity-purified the recombinant matrilin-2 protein 
from the conditioned medium of COS-1 cells transfected with 
matrilin-2 cDNA. We found that purified matrilin-2 was cleaved 
by ADAMTS4 after incubation at 37C for 24hours. A 39 KD N- 
terminal cleavage product and a 23 KD C-terminal matrilin cleav- 
age product was identified by both SELDI mass spectrometry 
and western blot analysis. Thus, purified recombinant MATN2 
that is free from GAGs or any other proteoglycans can be 
cleaved by ADAMTS4. To localize the ADAMTS4 cleavage site 
within matrilin-2, we incubated truncated MATN2 recombinant 
protein with ADAMTS4. Partial truncation of the unique domain of 
matrilin-2 reduced the cleavage, and deletion of the whole unique 
domain eliminated the cleavage by ADAMTS4. Thus, the unique 
domain of matrilin-2 was essential for ADAMTS4 proteolysis. To 
determine whether proteolysis of matrilin-2 in cartilage is de- 
pendent on growth factors that exert pro-inflammatory esponse, 
primary human articular chondrocytes were incubated with the 
medium containing matrilin-2 either in the presence or absence 
of TGF-b and IL-la. Treatment of chondrocytes with either TGF- 
b or IL-la significantly stimulates the proteolysis of matrilin-2 by 
ADAMTS4. This indicates that proteolysis of matrilin-2 in cartilage 
is dependent on the presence of TGF-b or IL-la. 
Summary: Our study demonstrated for the first time that 
ADAMTS4 (aggrecanase-1) is capable of cleaving matrilin-2, a 
non-proteoglycan matrix protein in a GAG independent manner. 
Our data further suggest that ADAMTS4 cleavage of matrilin- 
2 occurs in the unique domain, and is stimulated under pro- 
inflammatory conditions including IL-la. This cleavage will re- 
lease the matrix-binding vWF A domain of matrilin-2 from the car- 
tilage extracellular matrix, thereby contributing to the breakdown 
of matrilin network and cartilage degeneration during arthritis. 
